Maria Bernabeu

@mariabernabeu.bsky.social

Group Leader at EMBL Barcelona. Malaria, bioengineered vascular models, blood-brain barrier

Come to Biomalpar xxii!!! We have an outstanding line up of speakers!!! It is a true honor to be an organizer of Biomalpar. It was the first conference I ever attended during my 2nd PhD year so it feels special. And don't miss the beautiful poster image from Hannah Fleckenstein!

EMBL Events@events.embl.org · 8mo ago

Do you want to join a community working to reduce the devastating toll of #malaria by pushing forward new ideas, innovations, and strategies? 🦟 🧬 Registration is now open for #EMBLMalaria: https://s.embl.org/bmp26-01-bl ✍️ Submit your abstract by 18 Feb 🗓️ 27 – 29 May 2026 #BioMalPar

Thanks for the support of @caixaresearch.bsky.social to continue our efforts to use tissue engineering to study cerebral malaria. We will develop stem-cell derived immunocompetent BBB models with microglia to study malaria, in a side by side comparison with spatial transcriptomics in patients.

@caixaresearch.bsky.social · 9mo ago

1/ Cerebral malaria is a severe form of malaria that causes damage to the blood vessels in the brain. With a #HealthResearch grant, @mariabernabeu.bsky.social uses analytical techniques and human 3D models of blood vessels to ⬆️ our understanding and test new therapies. https://tinyurl.com/2vtjnwn6

I’ve been in Toronto at the #astmh meeting these past few days and last night some very good news was presented here: A new malaria drug has proven efficacious in a large trial and could soon be approved.🧪 My story in @science.org (and 🧵on why it's important to come): www.science.org/content/arti...

‘A sigh of relief’: New malaria drug succeeds in large clinical trial

As existing drugs falter because of resistance, the world gets a backup—but hard choices loom on how to use it

science.org

Just hot out of the press! Rory developed a 3D microvessel model that recapitulates physiological pericyte coverage. We found that Plasmodium falciparum egress products disrupt the barrier and halt ang-1 secretion. The activator AKB-9778 could rescue barrier disruption! Congratulations, Rory!

@rorykmlong.bsky.social · 10mo ago

Today my main PHD project in the lab of Dr. Maria Bernabeu was published! Using a 3D brain microvessel model, we show: 1) an unappreciated role of brain pericytes in cerebral malaria pathogenesis 2) Tie-2 activation by AKB-9778 as a potential therapeutic avenue www.embopress.org/doi/full/10....

Thank you @silvapereiralab.bsky.social for letting us contribute and learn about sequestration of Trypanosma congolense and develop our first bovine microvessels. Spoilert alert: it presents much higher binding than P. falciparium to bioengineered microvessels

Silva Pereira Lab (Parasite Vascular Interactions)@silvapereiralab.bsky.social · last yr.

Here's a short summary of our most recent paper, published today on @commsbio.bsky.social: We want to understand how Trypanosoma congolense cytoadheres, or sequesters, to the vascular endothelium because sequestration determines clinical outcome and disease severity. (1/7)

Congratulations to Dr. Rory Long, who successfully defended his thesis yesterday! Rory pulled out his project independently, and found that malaria products decrease secretion of Ang-1 in brain pericytes in complex 3Dmodels, and tested therapies that restore ang-Tie2 axis. Cannot be more proud!!!

BildBildBild

The @mimsumea.bsky.social , @scilifelab.se and @embl.org workshop "infection across scales" was a success. Special thanks to @mimsumea.bsky.social Oliver and Nora for being fantastic hosts and organizing once in a lifetime networking activities.

BildBildBild
The Laboratory for Molecular Infection Medicine Sweden (MIMS)@mimsumea.bsky.social · 2y ago

Opening of the Infection Biology Across Scales workshop in Umeå on 3-4 February. The workshop is organised by @embl.org, SciLifeLab and @mimsumea.bsky.social, focusing on exploring complementary platforms and capabilities of the 3 organizations in light of the most important scientific challenges.

Oliver Billker, MIMS Director, opening of the Infection Biology Across Scales workshop in Umeå  on 3-4 February 2025.

The Kowalinski group's latest study on trypanosome parasites reveals significant differences between the trypanosomal and human nuclear cap-binding complex. This key player in cellular RNA metabolism could be a potential target for novel anti-parasitic drugs. www.embl.org/news/science...

3D representation of a protein complex with fluorescent parasite cells in the background.

TODAY is the last day of abstract submission for @cshlmeetings.bsky.social Brain Barriers 2025...get them in so you will not miss presenting at one of the best CNS barriers meeting in the world! 🧠 + 🚧 #cshlbbb @caromenard666.bsky.social @ayalbenzvi.bsky.social

Brain Barriers

Cold Spring Harbor Laboratory Meetings & Courses -- a private, non-profit institution with research programs in cancer, neuroscience, plant biology, genomics, bioinformatics.

meetings.cshl.edu

Siegenthaler Lab@siegenthalerlab.bsky.social · 2y ago

🚨 CNS barriers scientists...come join us for #cshlbbb 2025! Submit your abstracts by January 24th...we pick MANY talks from abstracts - we look forward to seeing you in April!